Role of Molecular Typing in Live Related Donor Renal Transplantation.

[1]  A. Little,et al.  Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection. , 1998, Current opinion in hematology.

[2]  N. Mehra,et al.  Polymerase chain reaction--based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. , 1996, The Journal of infectious diseases.

[3]  F. Ikoma,et al.  Long-term kidney graft outcome based on HLA-DRB1 matching. , 1994, Transplantation proceedings.

[4]  F. Papola,et al.  Comparison between HLA-DR serologic typing and oligotyping in kidney transplant: a single center experience. , 1993, Transplantation proceedings.

[5]  J. Chapman,et al.  Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. , 1993, Transplantation.

[6]  M. Trucco,et al.  MOLECULAR COMPATIBILITY AND RENAL GRAFT SURVIVAL—THE HLA DQB1 GENOTYPING1 , 1993, Transplantation.

[7]  J. Soulillou,et al.  HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center study. , 1993, Transplantation proceedings.

[8]  G. Bein,et al.  Molecular matching in renal transplantation. , 1992, Transplantation proceedings.

[9]  C. Cardella,et al.  Tissue matching: who needs it? , 1992, Transplantation proceedings.

[10]  D. Gjertson,et al.  THE LARGE CENTER VARIATION IN HALF‐LIVES OF KIDNEY TRANSPLANTS 1,2,3 , 1992, Transplantation.

[11]  J. Chapman,et al.  Survival of DNA HLA-DR typed and matched cadaver kidney transplants , 1991, The Lancet.

[12]  B. Mach,et al.  APPLICATION OF HLA‐DR OLIGOTYPING TO 110 KIDNEY TRANSPLANT PATIENTS WITH DOUBTFUL SEROLOGICAL TYPING , 1991, Transplantation.

[13]  Eric O Long,et al.  Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain , 1986, The Journal of experimental medicine.

[14]  P. Terasaki,et al.  Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.

[15]  G. Heller,et al.  DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. , 1999, Blood.